MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

12 Nov 2022 Evaluate
The sales slipped to Rs. 1594.33 millions for the September 2022 quarter as against Rs. 1747.01 millions during the year-ago period.The company reported a drastic decline of -96.89% in the quarter ended September 2022 to Rs. 7.87  millions from Rs. 252.72 millions  .A decline of 142.30 millions was observed in the OP in the quarter ended September 2022 from 484.09 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1594.33 1747.01 -8.74 2238.22 3378.44 -33.75 5198.74 5631.78 -7.69
Other Income 6.14 13.55 -54.69 14.15 24.99 -43.38 51.98 34.53 50.54
PBIDT 142.30 484.09 -70.60 146.06 941.33 -84.48 1196.83 1245.63 -3.92
Interest 52.43 48.21 8.75 100.93 97.83 3.17 188.75 111.62 69.10
PBDT 89.87 435.88 -79.38 45.13 843.50 -94.65 1008.08 1134.01 -11.10
Depreciation 80.92 80.90 0.02 160.26 160.85 -0.37 321.52 222.82 44.30
PBT 8.95 354.98 -97.48 -115.13 682.65 -116.87 686.56 911.19 -24.65
TAX 1.08 102.26 -98.94 -24.94 197.95 -112.60 6.18 301.55 -97.95
Deferred Tax 1.08 27.26 -96.04 -24.94 52.95 -147.10 -143.02 141.09 -201.37
PAT 7.87 252.72 -96.89 -90.19 484.70 -118.61 680.38 609.64 11.60
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 8.93 27.71 -67.79 6.53 27.86 -76.58 23.02 22.12 4.09
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..